[HTML][HTML] Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
MDA Paskeh, F Ghadyani, M Hashemi… - Pharmacological …, 2023 - Elsevier
Cancer progression results from activation of various signaling networks. Among these,
PI3K/Akt signaling contributes to proliferation, invasion, and inhibition of apoptosis …
PI3K/Akt signaling contributes to proliferation, invasion, and inhibition of apoptosis …
[HTML][HTML] Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
M Entezari, M Ghanbarirad, A Taheriazam… - Biomedicine & …, 2022 - Elsevier
Among the different kinds of tumors threatening human life, lung cancer is one that is
commonly observed in both males and females. The aggressive behavior of lung cancer …
commonly observed in both males and females. The aggressive behavior of lung cancer …
NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Metastasis of tumor cells is a complex challenge and significantly diminishes the overall
survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) …
survival and prognosis of cancer patients. The epithelial‐to‐mesenchymal transition (EMT) …
Non-coding RNAs and macrophage interaction in tumor progression
M Entezari, M Sadrkhanloo, M Rashidi, SE Asnaf… - Critical reviews in …, 2022 - Elsevier
The macrophages are abundantly found in TME and their M2 polarization is in favor of tumor
malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage …
malignancy. On the other hand, non-coding RNAs (ncRNAs) can modulate macrophage …
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
S Mirzaei, MDA Paskeh, Y Saghari, A Zarrabi… - International Journal of …, 2022 - Elsevier
Transforming growth factor-beta (TGF-β) is a member of a family of secreted cytokines with
vital biological functions in cells. The abnormal expression of TGF-β signaling is a common …
vital biological functions in cells. The abnormal expression of TGF-β signaling is a common …
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
M Hashemi, E Sabouni, P Rahmanian… - Cellular & molecular …, 2023 - Springer
Hepatocellular carcinoma (HCC) is considered one of the greatest challenges to human life
and is the most common form of liver cancer. Treatment of HCC depends on chemotherapy …
and is the most common form of liver cancer. Treatment of HCC depends on chemotherapy …
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Abstract Changes in lifestyle such as physical activity and eating habits have been one of
the main reasons for development of various diseases in modern world, especially cancer …
the main reasons for development of various diseases in modern world, especially cancer …
[HTML][HTML] Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs
RR Al-Rashidi, SAM Noraldeen, AK Kareem… - Pharmacological …, 2023 - Elsevier
Prostate carcinoma is a malignant situation that arises from genomic alterations in the
prostate, leading to changes in tumorigenesis. The NF-κB pathway modulates various …
prostate, leading to changes in tumorigenesis. The NF-κB pathway modulates various …
[HTML][HTML] CircRNAs and lung cancer: insight into their roles in metastasis
J Ning, Y Luo, L Chen, G Xiao, G Tanzhu… - Biomedicine & …, 2023 - Elsevier
Lung cancer is the leading cause of cancer-related mortality worldwide. A major contributing
factor to the poor survival rates in lung cancer is the high prevalence of metastasis at the …
factor to the poor survival rates in lung cancer is the high prevalence of metastasis at the …